北京大学肿瘤医院胸部肿瘤内二科，副主任医师。

专业擅长：肺癌，胸膜间皮瘤，胸腺瘤和胸腺癌的内科和综合治疗。

代表性成果：以第一作者、通讯作者身份发表多篇论著，包括“Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer. Molecular analysis of cell-free DNA identifies distinct molecular features in patients with chemosensitive and chemorefractory small cell lung cancer” “Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study” “TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma”等。参与首都卫生发展科研专项项目、北京大学肿瘤医院临床研究专项基金等多项临床及基础课题研究。